Acquisition by Reza Zadno of 48575 shares of Procept Biorobotics subject to Rule 16b-3

PRCT Stock  USD 68.11  5.40  8.61%   
Slightly above 68 percent of all Procept Biorobotics' private investors are curious in acquiring. The analysis of overall sentiment of trading Procept Biorobotics Corp stock suggests that a large number of investors are confidant at this time. Procept Biorobotics' investing sentiment can be driven by a variety of factors including economic data, Procept Biorobotics' earnings reports, geopolitical events, and overall market trends.
  
Filed transaction by Procept Biorobotics Corp Director, Officer President, Ceo. Grant, award or other acquisition pursuant to Rule 16b-3

Read at macroaxis.com
Procept insider trading alert for acquisition of common stock by Reza Zadno, Director, Officer: President, Ceo, on 14th of October 2024. This event was filed by Procept Biorobotics Corp with SEC on 2024-03-06. SEC Form: Changes in beneficial ownership

Cash Flow Correlation

Procept Biorobotics' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Procept Biorobotics' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Procept Biorobotics Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Procept Biorobotics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Procept Biorobotics Corp Historical Investor Sentiment

Investor biases related to Procept Biorobotics' public news can be used to forecast risks associated with an investment in Procept. The trend in average sentiment can be used to explain how an investor holding Procept can time the market purely based on public headlines and social activities around Procept Biorobotics Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Procept Biorobotics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Procept Biorobotics and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Procept Biorobotics news discussions. The higher the estimate score, the more favorable the investor's outlook on Procept Biorobotics.

Procept Biorobotics Maximum Pain Price Across April 17th 2025 Option Contracts

Procept Biorobotics' options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Procept Biorobotics close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Procept Biorobotics' options.

Procept Biorobotics Fundamental Analysis

We analyze Procept Biorobotics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Procept Biorobotics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Procept Biorobotics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Cash Flow From Operations

Cash Flow From Operations Comparative Analysis

Procept Biorobotics is currently under evaluation in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.

Procept Biorobotics Corp Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Procept Biorobotics stock to make a market-neutral strategy. Peer analysis of Procept Biorobotics could also be used in its relative valuation, which is a method of valuing Procept Biorobotics by comparing valuation metrics with similar companies.

Peers

Procept Biorobotics Related Equities

SGHTSight Sciences   12.85   
0%
100.0%
LUNGPulmonx Corp   6.22   
0%
48.0%
SRDXSurModics   1.01   
0%
7.0%
ESTAEstablishment Labs   0.78   
0%
6.0%
KIDSOrthopediatrics Corp   0.22   
0%
1.0%
TMCITreace Medical   0.21   
0%
1.0%
FNAParagon 28   0.31   
2.0%
0%
LIVNLivaNova PLC   0.60   
4.0%
0%
RXSTRxsight   0.82   
6.0%
0%
ITGRInteger Holdings   1.15   
8.0%
0%
OFIXOrthofix Medical   1.43   
11.0%
0%
SIBNSi Bone   1.57   
12.0%
0%
CNMDCONMED   2.10   
16.0%
0%
NPCENeuropace   2.60   
20.0%
0%
AXGNAxogen   3.23   
25.0%
0%

Additional Tools for Procept Stock Analysis

When running Procept Biorobotics' price analysis, check to measure Procept Biorobotics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procept Biorobotics is operating at the current time. Most of Procept Biorobotics' value examination focuses on studying past and present price action to predict the probability of Procept Biorobotics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procept Biorobotics' price. Additionally, you may evaluate how the addition of Procept Biorobotics to your portfolios can decrease your overall portfolio volatility.